Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.561
+0.021 (3.87%)
Nov 21, 2024, 1:24 PM EST - Market open

MTNB Revenue

In the year 2023, Matinas BioPharma Holdings had annual revenue of $1.10M, down -65.62%.

Revenue (ttm)
$1.10M
Revenue Growth
-65.62%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
2.81M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.10M-2.09M-65.62%
Dec 31, 20223.19M3.16M9,560.61%
Dec 31, 202133.00K-125.33K-79.16%
Dec 31, 2020158.33K68.52K76.29%
Dec 31, 201989.81K-29.94K-25.00%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.